{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:28:11Z","timestamp":1789518491579,"version":"build-2803163510"},"reference-count":116,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China (NSFC)","award":["82271851"],"award-info":[{"award-number":["82271851"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["81901663"],"award-info":[{"award-number":["81901663"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["ZYQNBJRC2023-01"],"award-info":[{"award-number":["ZYQNBJRC2023-01"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["2023GGJS048"],"award-info":[{"award-number":["2023GGJS048"]}]},{"name":"Central Plain Young Top Talents Program","award":["82271851"],"award-info":[{"award-number":["82271851"]}]},{"name":"Central Plain Young Top Talents Program","award":["81901663"],"award-info":[{"award-number":["81901663"]}]},{"name":"Central Plain Young Top Talents Program","award":["ZYQNBJRC2023-01"],"award-info":[{"award-number":["ZYQNBJRC2023-01"]}]},{"name":"Central Plain Young Top Talents Program","award":["2023GGJS048"],"award-info":[{"award-number":["2023GGJS048"]}]},{"name":"Young Backbone Teachers Training Program of Henan Province","award":["82271851"],"award-info":[{"award-number":["82271851"]}]},{"name":"Young Backbone Teachers Training Program of Henan Province","award":["81901663"],"award-info":[{"award-number":["81901663"]}]},{"name":"Young Backbone Teachers Training Program of Henan Province","award":["ZYQNBJRC2023-01"],"award-info":[{"award-number":["ZYQNBJRC2023-01"]}]},{"name":"Young Backbone Teachers Training Program of Henan Province","award":["2023GGJS048"],"award-info":[{"award-number":["2023GGJS048"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Narcolepsy type 1 (NT1) is an uncommon, persistent sleep disorder distinguished by significant daytime sleepiness, episodes of cataplexy, and irregularities in rapid eye movement sleep. The etiology of NT1 is linked to the destruction of hypothalamic neurons responsible for the synthesis of the wake-promoting neuropeptide known as hypothalamic orexin. The pathophysiological mechanisms underlying NT1 remain inadequately elucidated; however, a model that incorporates the interplay of genetic predisposition, environmental influences, immune system factors, and a deficiency in hypocretin (HCRT) provides a framework for elucidating the pathogenesis of NT1. The prevalence of NT1 has been observed to rise following influenza A (H1N1) pdm09 and the administration of the Pandemrix influenza vaccine. The strong association between narcolepsy and the HLA-DQB1*06:02 allele strongly indicates an autoimmune etiology for this condition. Increasing evidence suggests that T cells play a critical role in this autoimmune-mediated HCRT neuronal loss. Studies have identified specific T cell subsets, including CD4+ and CD8+ T cells, that target HCRT neurons, contributing to their destruction. Clarifying the pathogenesis of NT1 driven by autoimmune T cells is crucial for the development of effective therapeutic interventions for this disorder. This review examines the risk factors associated with the pathogenesis of NT1, explores the role of T cells within the immune system in the progression of NT1, and evaluates immune-mediated animal models alongside prospective immunotherapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms252211914","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T06:27:39Z","timestamp":1730874459000},"page":"11914","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of T Cells in the Pathogenesis of Narcolepsy Type 1: A Narrative Review"],"prefix":"10.3390","volume":"25","author":[{"given":"Wenqi","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanshuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, C., Wang, Q., Ji, B., Pan, Y., Xu, C., Cheng, B., Bai, B., and Chen, J. (2018). The Orexin\/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front. Mol. Neurosci., 11.","DOI":"10.3389\/fnmol.2018.00220"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: Highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"ref_4","unstructured":"Slowik, J.M., Collen, J.F., and Yow, A.G. (2024). Narcolepsy. StatPearls, StatPearls Publishing LLC."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"zsac325","DOI":"10.1093\/sleep\/zsac325","article-title":"Changed epidemiology of narcolepsy before, during, and after the 2009 H1N1 pandemic: A nationwide narcolepsy surveillance network study in mainland China, 1990-2017","volume":"46","author":"Wang","year":"2023","journal-title":"Sleep"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0035-1550152","article-title":"Narcolepsy during Childhood: An Update","volume":"46","author":"Rocca","year":"2015","journal-title":"Neuropediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"Kilduff","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.26300","article-title":"Reduced Numbers of Corticotropin-Releasing Hormone Neurons in Narcolepsy Type 1","volume":"91","author":"Shan","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: Loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/brain\/awab455","article-title":"Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy","volume":"145","author":"Frieser","year":"2022","journal-title":"Brain"},{"key":"ref_15","first-page":"1119","article-title":"Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy","volume":"31","author":"Mishima","year":"2008","journal-title":"Sleep"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11910-018-0851-5","article-title":"Narcolepsy Associated with Pandemrix Vaccine","volume":"18","author":"Sarkanen","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(13)70238-X","article-title":"Pandemic influenza A H1N1 vaccines and narcolepsy: Vaccine safety surveillance in action","volume":"14","author":"Barker","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lecendreux, M., Churlaud, G., Pitoiset, F., Regnault, A., Tran, T.A., Liblau, R., Klatzmann, D., and Rosenzwajg, M. (2017). Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169836"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Bayer","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_25","first-page":"zsw036","article-title":"Anti-Tribbles Pseudokinase 2 (TRIB2)-Immunization Modulates Hypocretin\/Orexin Neuronal Functions","volume":"40","author":"Tanaka","year":"2017","journal-title":"Sleep"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/acn3.50908","article-title":"Children with Narcolepsy type 1 have increased T-cell responses to orexins","volume":"6","author":"Cogswell","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41577-023-00902-9","article-title":"The immunopathogenesis of narcolepsy type 1","volume":"24","author":"Liblau","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","first-page":"66","article-title":"Autoimmunity: A new clue to sleepiness","volume":"14","author":"Kugelberg","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group","volume":"51","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","article-title":"HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy","volume":"96","author":"Ollila","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/hmg\/ddu480","article-title":"New susceptibility variants to narcolepsy identified in HLA class II region","volume":"24","author":"Miyagawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humimm.2006.10.006","article-title":"DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans","volume":"68","author":"Hong","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00005-016-0435-5","article-title":"Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias","volume":"64","author":"Vrana","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5665\/sleep.5532","article-title":"Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity","volume":"39","author":"Tafti","year":"2016","journal-title":"Sleep"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0039.2012.01948.x","article-title":"HLA-DQ association and allele competition in Chinese narcolepsy","volume":"80","author":"Han","year":"2012","journal-title":"Tissue Antigens"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","article-title":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","volume":"43","author":"Singh","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng.734","article-title":"Common variants in P2RY11 are associated with narcolepsy","volume":"43","author":"Kornum","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbi.2015.05.003","article-title":"A polymorphism in CCR1\/CCR3 is associated with narcolepsy","volume":"49","author":"Toyoda","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Faraco, J., Lin, L., Kornum, B.R., Kenny, E.E., Trynka, G., Einen, M., Rico, T.J., Lichtner, P., Dauvilliers, Y., and Arnulf, I. (2013). ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003270"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/gtmb.2013.0391","article-title":"Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons","volume":"18","author":"Cingoz","year":"2014","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ng.231","article-title":"Variant between CPT1B and CHKB associated with susceptibility to narcolepsy","volume":"40","author":"Miyagawa","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/ejhg.2015.4","article-title":"EIF3G is associated with narcolepsy across ethnicities","volume":"23","author":"Holm","year":"2015","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Han, F., Faraco, J., Dong, X.S., Ollila, H.M., Lin, L., Li, J., An, P., Wang, S., Jiang, K.W., and Gao, Z.C. (2013). Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003880"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Miyagawa, T., Honda, M., Kawashima, M., Shimada, M., Tanaka, S., Honda, Y., and Tokunaga, K. (2009). Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia). PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005394"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2869.2009.00756.x","article-title":"Medical exposures in youth and the frequency of narcolepsy with cataplexy: A population-based case-control study in genetically predisposed people","volume":"19","author":"Koepsell","year":"2010","journal-title":"J. Sleep Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.genom.4.070802.110432","article-title":"The genetics of narcolepsy","volume":"4","author":"Chabas","year":"2003","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(04)15951-5","article-title":"Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway","volume":"363","author":"Khatami","year":"2004","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Partinen, M., Saarenp\u00e4\u00e4-Heikkil\u00e4, O., Ilveskoski, I., Hublin, C., Linna, M., Ols\u00e9n, P., Nokelainen, P., Al\u00e9n, R., Wallden, T., and Espo, M. (2012). Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033723"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., Himanen, S.L., Hublin, C., Julkunen, I., and Ols\u00e9n, P. (2012). AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033536"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"Heier","year":"2013","journal-title":"Sleep Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2020.03.019","article-title":"Anti-streptococcal antibodies in Chinese patients with type-1 narcolepsy","volume":"72","author":"Ding","year":"2020","journal-title":"Sleep Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/INF.0000000000002398","article-title":"Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic","volume":"38","author":"Edwards","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.47936\/encephalitis.2021.00010","article-title":"Narcolepsy, autoimmunity, and influenza A H1N1 vaccination","volume":"1","author":"Sunwoo","year":"2021","journal-title":"Encephalitis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an Adjuvant System containing \u03b1-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Vaughn","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_59","first-page":"1459394","article-title":"Adjuvants: Classification, Modus Operandi, and Licensing","volume":"2016","author":"Lunardelli","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Facciol\u00e0, A., Visalli, G., Lagan\u00e0, A., and Di Pietro, A. (2022). An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines, 10.","DOI":"10.3390\/vaccines10050819"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1016\/j.vaccine.2009.01.040","article-title":"Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/joim.12150","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: A population- and registry-based cohort study with over 2 years of follow-up","volume":"275","author":"Persson","year":"2014","journal-title":"J. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: The role of H1N1 infection and vaccination","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/sleep\/33.7.857","article-title":"The trouble with Tribbles: Do antibodies against TRIB2 cause narcolepsy?","volume":"33","author":"Lim","year":"2010","journal-title":"Sleep"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","article-title":"Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy","volume":"33","author":"Toyoda","year":"2010","journal-title":"Sleep"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/sleep\/29.5.633","article-title":"Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: Anti-Hcrt system antibody in narcolepsy","volume":"29","author":"Tanaka","year":"2006","journal-title":"Sleep"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy\u2014Clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-12-820683-6.00012-9","article-title":"Narcolepsy Type I as an autoimmune disorder","volume":"Volume 181","author":"Kornum","year":"2021","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","article-title":"Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy","volume":"115","author":"Luo","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jneuroim.2019.04.009","article-title":"H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls","volume":"332","author":"Schinkelshoek","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lind, A., Marzinotto, I., Brigatti, C., Ramelius, A., Piemonti, L., and Lampasona, V. (2021). A\/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-83543-z"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1084\/jem.20160897","article-title":"High-dimensional single-cell analysis reveals the immune signature of narcolepsy","volume":"213","author":"Hartmann","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yoshida-Tanaka, K., Shimada, M., Honda, Y., Fujimoto, A., Tokunaga, K., Honda, M., and Miyagawa, T. (2023). Narcolepsy type I-associated DNA methylation and gene expression changes in the human leukocyte antigen region. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37511-4"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.1984.tb02144.x","article-title":"HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive","volume":"24","author":"Juji","year":"1984","journal-title":"Tissue Antigens"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.sleep.2017.11.1150","article-title":"Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease","volume":"44","author":"Moresco","year":"2018","journal-title":"Sleep Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"zsy223","DOI":"10.1093\/sleep\/zsy223","article-title":"Specific T-cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence","volume":"42","author":"Lippert","year":"2019","journal-title":"Sleep"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/nyas.12793","article-title":"Type 1 narcolepsy: A CD8(+) T cell-mediated disease?","volume":"1351","author":"Degn","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocn.2024.01.007","article-title":"Association between cytokines and fatigue in patients with type 1 narcolepsy","volume":"120","author":"Yang","year":"2024","journal-title":"J. Clin. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2018.07.021","article-title":"Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients","volume":"94","author":"Nguyen","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature17979","article-title":"Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help","volume":"533","author":"Iijima","year":"2016","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","article-title":"Cytotoxic CD8+ T cell-neuron interactions: Perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death","volume":"29","author":"Meuth","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int. Rev. Immunol."},{"key":"ref_84","first-page":"1305","article-title":"Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy","volume":"70","author":"Dauvilliers","year":"2013","journal-title":"JAMA Neurol"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Yshii","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-019-08774-1","article-title":"CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens","volume":"10","author":"Pedersen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The neurobiological basis of narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_88","first-page":"792687","article-title":"Narcolepsy as an immune-mediated disease","volume":"2014","year":"2014","journal-title":"Sleep Disord."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","article-title":"Deconstructing the peptide-MHC specificity of T cell recognition","volume":"157","author":"Birnbaum","year":"2014","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12026-014-8513-4","article-title":"History of narcolepsy at Stanford University","volume":"58","author":"Mignot","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1051\/jbio\/2019026","article-title":"Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T\u2009cell biology and molecular mimicry with flu epitopes","volume":"213","author":"Ravel","year":"2019","journal-title":"Biol. Aujourdhui"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41467-021-22637-8","article-title":"Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1","volume":"12","author":"Vuorela","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","article-title":"Passive transfer of narcolepsy: Anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice","volume":"45","author":"Katzav","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.metabol.2006.07.011","article-title":"Narcolepsy and the hypocretins","volume":"55","author":"Wurtman","year":"2006","journal-title":"Metab. Clin. Exp."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1523\/JNEUROSCI.0586-04.2004","article-title":"Behavioral state instability in orexin knock-out mice","volume":"24","author":"Mochizuki","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1046\/j.1471-4159.2002.01141.x","article-title":"Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons","volume":"82","author":"Reti","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41593-019-0349-8","article-title":"Single-cell transcriptomic analysis of the lateral hypothalamic area reveals molecularly distinct populations of inhibitory and excitatory neurons","volume":"22","author":"Mickelsen","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Toyoda, H., Honda, Y., Tanaka, S., Miyagawa, T., Honda, M., Honda, K., Tokunaga, K., and Kodama, T. (2017). Narcolepsy susceptibility gene CCR3 modulates sleep-wake patterns in mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187888"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/NSS.S275931","article-title":"Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder","volume":"13","author":"Giannoccaro","year":"2021","journal-title":"Nat. Sci. Sleep"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins--a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00415-007-0594-8","article-title":"Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy","volume":"254","author":"Fronczek","year":"2007","journal-title":"J. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00415-008-0983-7","article-title":"Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy","volume":"255","author":"Plazzi","year":"2008","journal-title":"J. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0030-1267993","article-title":"Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy","volume":"41","author":"Knudsen","year":"2010","journal-title":"Neuropediatrics"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.berh.2011.11.002","article-title":"Glucocorticoids","volume":"25","author":"Spies","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S0004-282X2007000200028","article-title":"Report of two narcoleptic patients with remission of hypersomnolence following use of prednisone","volume":"65","author":"Coelho","year":"2007","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J. Sleep Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2869.2011.00985.x","article-title":"A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy","volume":"21","author":"Donjacour","year":"2012","journal-title":"J. Sleep Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/TCRM.S134398","article-title":"Alemtuzumab: A review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis","volume":"13","author":"Guarnera","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/tcrm.2007.3.2.259","article-title":"Natalizumab: A new treatment for relapsing remitting multiple sclerosis","volume":"3","author":"Hutchinson","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"zsaa050","DOI":"10.1093\/sleep\/zsaa050","article-title":"Treatment of narcolepsy with natalizumab","volume":"43","author":"Scammell","year":"2020","journal-title":"Sleep"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.0073-14.2014","article-title":"Conditional ablation of orexin\/hypocretin neurons: A new mouse model for the study of narcolepsy and orexin system function","volume":"34","author":"Tabuchi","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5665\/sleep.2080","article-title":"Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy","volume":"35","author":"Andlauer","year":"2012","journal-title":"Sleep"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11914\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:27:20Z","timestamp":1760113640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":116,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252211914"],"URL":"https:\/\/doi.org\/10.3390\/ijms252211914","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]}}}